Omada Health, Inc.
For the period ended Sep 30, 2026. Filed Nov 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss
(in thousands, except per-share data, unaudited)
| Three Months Ended September 30, · Nine Months Ended September 30, | ||||||
|---|---|---|---|---|---|---|
| 2026 · 2025 · 2026 · 2025 | ||||||
| Revenue | ||||||
| Services (1) | $85,106 | $62,936 | $235,392 | $169,392 | ||
| Hardware (2) | 6,200 | 5,094 | 21,797 | 14,972 | ||
| Total revenue | 91,306 | 68,030 | 257,189 | 184,364 | ||
| Cost of revenue | ||||||
| Services (3) | 13,174 | 12,654 | 41,232 | 38,071 | ||
| Hardware | 8,850 | 10,305 | 34,195 | 29,016 | ||
| Total cost of revenue | 22,024 | 22,959 | 75,427 | 67,087 | ||
| Gross profit | 69,282 | 45,071 | 181,762 | 117,277 | ||
| Operating expenses | ||||||
| Research and development (4) | 15,271 | 10,301 | 42,593 | 29,131 | ||
| Sales and marketing (5) | 29,107 | 22,943 | 85,782 | 65,431 | ||
| General and administrative (6) | 20,084 | 14,340 | 49,799 | 37,968 | ||
| Total operating expenses | 64,462 | 47,584 | 178,174 | 132,530 | ||
| Operating income (loss) | 4,820 | (2,513) | 3,588 | (15,253) | ||
| Other income (expense), net | ||||||
| Interest expense | (262) | (353) | (294) | (2,521) | ||
| Interest income | 1,993 | 2,009 | 5,581 | 3,414 | ||
| Loss on debt extinguishment | - | (2,109) | - | (2,109) | ||
| Change in fair value of warrant liabilities | - | (212) | - | (1,468) | ||
| Total other income (expense), net | 1,731 | (665) | 5,287 | (2,684) | ||
| Income (loss) before provision for income taxes | 6,551 | (3,178) | 8,875 | (17,937) | ||
| Provision for income taxes | - | - | - | - | ||
| Net income (loss) and comprehensive income (loss) | $6,551 | $(3,178) | $8,875 | $(17,937) | ||
| Net income (loss) per share | ||||||
| Basic | $0.11 | $(0.06) | $0.15 | $(0.61) | ||
| Diluted | $0.10 | $(0.06) | $0.14 | $(0.61) | ||
| Weighted-average shares outstanding | ||||||
| Basic | 61,499 | 57,658 | 60,045 | 29,421 | ||
| Diluted | 67,121 | 57,658 | 64,561 | 29,421 | ||
(1)Includes amounts from a related party of $53.7 million and $41.8 million for the three months ended September 30, 2026 and 2025, respectively, and $151.1 million and $108.2 million for the nine months ended September 30, 2026 and 2025, respectively.
(2)Includes amounts from a related party of $4.0 million and $3.0 million for the three months ended September 30, 2026 and 2025, respectively, and $13.9 million and $9.0 million for the nine months ended September 30, 2026 and 2025, respectively.
(3)Includes amounts from a related party of $1.4 million and $1.4 million for the three months ended September 30, 2026 and 2025, respectively, and $4.1 million and $3.8 million for the nine months ended September 30, 2026 and 2025, respectively.
(4)Includes amounts from a related party of $0.9 million and $0.6 million for the three months ended September 30, 2026 and 2025, respectively, and $2.4 million and $1.6 million for the nine months ended September 30, 2026 and 2025, respectively.
(5)Includes amounts from a related party of $8.7 million and $7.1 million for the three months ended September 30, 2026 and 2025, respectively, and $25.6 million and $19.3 million for the nine months ended September 30, 2026 and 2025, respectively.
(6)Includes amounts from a related party of $0.4 million and $0.4 million for the three months ended September 30, 2026 and 2025, respectively, and $1.4 million and $1.1 million for the nine months ended September 30, 2026 and 2025, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.